|
|
||||||||
Ann Thorac Surg 2005;79:646-654
© 2005 The Society of Thoracic Surgeons
a Department of Surgery, Division of Cardiothoracic Surgery, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
Accepted for publication July 6, 2004.
* Address reprint requests to Dr Buckberg, Division of Cardiothoracic Surgery, 62-258, Center for the Health Sciences, Los Angeles, CA 90095-1701 (E-mail: gdbuckberg{at}mednet.ucla.edu).
Presented at the Fortieth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 2628, 2004.
BACKGROUND: The effects of pretreatment with cariporide (HOE 642 Aventis Pharma, Strasbourg - Cedex, France), a Na+H+ exchanger (NHE) blocker, were studied in a cerebral ischemiareperfusion model of hypothermic arrest.
METHODS: Fifteen Yorkshire-Duroc pigs (37.1 ± 4.2 kg) underwent femoraljugular bypass and 90 minutes of deep hypothermic circulatory arrest at 19°C. Ten animals were untreated, whereas 5 received 5 mg/kg of intravenous cariporide before cooling. After rewarming and off cardiopulmonary bypass, the pigs were weaned from anesthesia and followed for 24 hours. A standardized neurologic scoring system assessed brain functional recovery. Biochemical markers were used to analyze cellular injury. Control studies without circulatory arrest were done in 2 animals that underwent similar cooling and rewarming.
RESULTS: Neurologic recovery was rapid and complete in the nonischemic controls and in all pretreated animals. Conversely, at 24 hours, all untreated pigs exhibited a cloudy or stuporous level of consciousness, abnormal positioning, and with only one exception, could not sit or stand. The gradation of neurologic score (evaluating central nervous system, motor and sensory functions, respiration condition, level of consciousness, and behavior) was 0 ± 0 (0 = normal, 500 = brain death) in the treated group, compared with 124 ± 59 in the untreated animals. Biochemical analysis showed every variable of whole-body injury (including conjugated dienes (p < 0.05), serum aspartate amino transferase (p < 0.01), creatine kinase p < 0.001) and endothelin-1 (p < 0.001) to be higher in the untreated group.
CONCLUSIONS: NHE function alters experimental brain ischemiareperfusion damage. These observations imply that NHE inhibition therapy before ischemia may improve neurologic protection in adult and infant patients undergoing cerebral ischemia during procedures that use hypothermic circulatory arrest.
This article has been cited by other articles:
![]() |
M. Kawata, S. Takamoto, K. Kitahori, H. Tsukihara, T. Morota, M. Ono, N. Motomura, A. Murakami, and Y. Suematsu Intermittent pressure augmentation during retrograde cerebral perfusion under moderate hypothermia provides adequate neuroprotection: An experimental study J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 80 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawata, S. Takamoto, K. Kitahori, H. Tsukihara, T. Morota, M. Ono, N. Motomura, A. Murakami, and Y. Suematsu Erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest: An experimental study in a canine model J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1331 - 1337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |